Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.12 USD | +0.35% | +0.20% | +24.99% |
04-12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
04-08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.99% | 10.12B | |
+25.32% | 661B | |
+26.74% | 566B | |
-6.57% | 352B | |
+20.26% | 332B | |
+2.79% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.14% | 145B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.27B, vs. Street Est of $1.22B